Overview

PP-405, often referred to as PP405, is an innovative small-molecule research compound currently under development by Pelage Pharmaceuticals. This compound primarily functions as an inhibitor of the mitochondrial pyruvate carrier (MPC) complex, targeting both MPC1 and MPC2. Recent literature highlights its potential role in modifying intracellular metabolic pathways, making it a subject of interest in ongoing research endeavors. Currently, PP-405 is undergoing preclinical and early clinical studies, exploring its mechanistic impact on cellular metabolism, particularly in various research applications.

Key Features

Research compound targeting mitochondrial pyruvate carrier
Inhibits MPC1 and MPC2 specifically
Emerging literature on its role in metabolic pathways
Undergoing preclinical and early clinical studies
Potential applications in diverse research fields

Specifications

Property	Details
Category	Liquids
Research Phase	Preclinical/Early Clinical

FAQ

What is PP-405 used for?

PP-405 is primarily used in research settings to study its effects on mitochondrial function and cellular metabolism.

How is PP-405 administered?

PP-405 is available in liquid form, making it easy to incorporate into various research protocols.

Is PP-405 safe for human consumption?

PP-405 is a research compound and should only be used in laboratory settings under appropriate supervision and compliance with regulations.

Explore the potential of PP-405 in your research today.

Related Products

Browse more in Liquids.

Always read the label and use products as directed. Consult a qualified professional where appropriate.

Form	Liquid
Strength	50mcg per ml/30ml/1.5mg, 100mcg per ml/30ml/3mg

PP-405